“…Recently, a bunch of fibrosis-related inflammatory mediators have been successively discovered. These fibro-inflammatory mediators include IL-1 family (IL-1α, IL-1β, IL-18, IL-33, IL-36 α, IL-36β and IL-36γ) [ 107 ], Th1 cytokine (IFN- γ) [ 108 ], Th2 cytokines (IL-4, IL-5, IL-10 and IL-13), Th17 cytokines (IL-17 and IL-22), innate immune cell-derived proinflammatory cytokines (IL-6 and TNF- α), growth factors (TGF-β, PDGF, CTGF, IGF, FGF, EGF and VEGF) and chemokines (CCL2, CCL3, CCL4, CCL20) [ 109 ]. Furthermore, Kotsiou et al [ 110 ] have documented that IL-33/ST2 (suppression of tumorigenicity 2) axis can facilitate EMT process of various cell types and abnormal FB proliferation, ultimately leading to tissue fibrosis.…”